Drug Trial Radar · NCT03403985
Long-term Evaluation of Direct Pulp Capping
Last checked: Nov 19, 2026Latest source record: Sep 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Planned (sponsor's estimate)
Start
Jun 1, 2017
Primary completion
Jun 28, 2017
Study completion Jun 2022
Sponsor
- Lead sponsor
- Jordan University of Science and TechnologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 19, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Calcium hydroxide and mineral trioxide aggregate have been used in vital pulp therapy with variable outcomes recorded by different study. They will be compared when used for direct pulp capping in cariously exposed mature permanent teeth.
Conditions
- Dental Pulp Capping
- Dental Caries Extending to Pulp
Interventions
Calcium Hydroxide (Ca(OH)2)Drug
Ca(OH)2 will be used in this group
Mineral Trioxide AggregateDrug
MTA will be used in this group
Primary outcomes
What the sponsor says the trial is designed to measure.
- clinical vital pulp therapy successTime frame: from date of randomization until failure reported for up to 100 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dental health center
Irbid, Jordan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.